🇺🇸 FDA
Pipeline program

HTX-011B

HTX-011-C2015-203

Phase 2 small_molecule completed

Quick answer

HTX-011B for Postoperative Pain is a Phase 2 program (small_molecule) at HERON THERAPEUTICS, INC. /DE/ with 1 ClinicalTrials.gov record(s).

Program details

Company
HERON THERAPEUTICS, INC. /DE/
Indication
Postoperative Pain
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials